Overview

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This study will assess the analgesic efficacy of DSG 1% compared to placebo in the reduction of the pain associated with acute blunt trauma injuries.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Diclofenac